Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park
MORRISVILLE, N.C., Jan. 27, 2025 /PRNewswire/ -- Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its cutting-edge Center of Excellence for Biologics and Cell and Gene Therapy in the heart of Research Triangle Park (RTP), North Carolina. The new facility expands Solvias' global network of centers and reinforces its commitment to advancing transformative therapies for cancer and rare diseases.
Spanning 50,000 square feet, the new center is Solvias' flagship North American site for large molecule analytical services designed to accelerate the development and commercialization of innovative biologics. The facility will bring approximately 200 new jobs to the Raleigh-Durham area over the next three years and is being rolled out in two phases:
Phase 1: A 20,000-square-foot space for cGMP release testing—featuring cell-based potency and molecular assays—operational immediately.
Phase 2: An additional 30,000 square feet expected to open in July 2025, offering expanded capabilities for stability testing and advanced biophysical characterization.
Equipped with state-of-the art analytical instrumentation, laboratory automation, and advanced digital management systems, the new center offers comprehensive GMP testing for cell and gene therapies, monoclonal antibodies (mAbs), and other biologics, from preclinical stages to commercial release.
'This Center of Excellence in RTP is a milestone in Solvias' global growth journey,' said Archie Cullen, Chief Executive Officer of Solvias. 'Combining our team's expertise with advanced technology, we aim to set a new benchmark for delivering high-quality, reliable analytical support. It's an honor to partner with our clients in bringing groundbreaking therapies to patients worldwide.'
'We are focused on helping our clients succeed with our analytical expertise. We are hiring the best possible talent to be technical partners for our clients, helping them bring therapies to market faster and more efficiently. With this investment, we are committed to be an integral part of the US biopharma innovation ecosystem,' said Ilya Koltover, Chief Commercial Officer of Solvias.
Solvias' new center expands its global footprint to six centers of excellence and marks the company's second site in North America. For more information on Solvias' new Center of Excellence in RTP, visit solvias.com.
About Solvias
Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life sciences industry. Its expert team combines decades of experience with regulatory expertise across small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release and API development for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards. For more information, visit solvias.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Health New England to replace Humira coverage with lower-cost biosimilars
SPRINGFIELD, Mass. (WWLP) – Health New England announced Monday that it will shift coverage of the biologic drug Humira to more affordable FDA-approved biosimilars starting next month for members of its commercial health plans. Markey playing defense against GOP clean energy plans Effective July 1, the not-for-profit health insurer will cover Amjevita by Nuvaila and Hadlima instead of Humira, as part of a broader effort to manage rising health care costs while maintaining access to effective treatments. Humira is used to treat several chronic inflammatory conditions, including rheumatoid arthritis, Crohn's disease, and plaque psoriasis. 'Biologic medications like Humira are complex treatments that carry significant cost. Its biosimilars provide a meaningful opportunity to enhance affordability for the health care ecosystem while members continue to get the full benefits of the medication,' said Gary Tereso, PharmD, Director of Pharmacy Services at Health New England. Biologic drugs are made from living organisms and are typically more expensive than other medications. Biosimilars are developed to be nearly identical in safety, potency, and efficacy to the original biologic, but at a significantly lower cost. The shift in coverage is intended to make treatment more accessible and financially sustainable for members and employer groups alike. Health New England is directly reaching out to members who are currently prescribed Humira, along with their health care providers and pharmacies, to assist with the transition. The company said it will continue monitoring the biosimilar marketplace to ensure members receive both high-quality care and cost-effective treatment options. WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
13 minutes ago
- Yahoo
Queclink Launches GL52RP: Compact LoRa Tracker Built for Long-Term Asset Security
SHANGHAI, June 10, 2025 /PRNewswire/ -- Queclink, a world-leading provider of IoT devices and solutions, today introduces the GL52RP, a compact LoRaWAN tracker built for asset monitoring, stolen vehicle recovery, and finance-related applications. With its long-range communication, extended battery life, and discreet design, the GL52RP is tailored for businesses looking to reduce operational overhead while improving visibility across assets. As low-power wide-area (LPWA) technologies continue gaining ground in the IoT sector, LoRa has emerged as a preferred alternative to cellular networks in asset tracking. Its ability to maintain connectivity over long distances with minimal power use makes it well-suited for industries such as logistics, mobility, and security. With LoRaWAN infrastructure expanding globally, adoption is rising across both developed and emerging markets. The GL52RP is especially relevant in regions like Brazil, where local regulations require strong anti-jamming performance. Thanks to LoRa's resilience in congested or low-signal areas, the device provides reliable communication even in environments where traditional cellular trackers may falter. Its compact design enables discreet mounting on vehicles, motorcycles, and movable assets, supporting both theft prevention and recovery. "We're seeing growing demand in LATAM for tracking solutions that go beyond what cellular can offer. In Brazil, it is already a reality since long time," said Marcelo Orsi, Sales Director for the LATAM region at Queclink. "With LoRa-based communication, strong resistance to jamming, and long standby time, the GL52RP is purpose-built for local security and compliance needs." In addition to its connectivity, the GL52RP features a high-sensitivity GNSS module and a built-in motion sensor for accurate location reporting and movement alerts. It's intelligent power management allows it to operate for several years in low-reporting modes, making it ideal for long-term, low-maintenance deployments. The device also supports various working modes—continuous, scheduled, and sleep—to give users more control over data use and energy consumption. The launch of the GL52RP marks Queclink's continued investment in LPWA innovation, providing businesses with practical, future-ready solutions for asset protection. Certified in key global regions, including Anatel approval for Brazil, the GL52RP supports major LoRaWAN frequency bands, ensuring seamless deployment across Latin America, Europe, and North America. The GL52RP is making its official debut at Exposec in São Paulo and also will be showcased at upcoming IoT events in the U.S. And Europe. Attendees can visit Booth D11 to see how this device is delivering long-term asset tracking with simplicity, endurance, and smart connectivity. View original content to download multimedia: SOURCE Queclink Wireless Solutions Co., Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
European Shoppers Hunt for Bargains Amid Rising Economic and Political Pessimism
BCG's Survey of Over 16,000 European Consumers Finds 54% Are Pessimistic About Their Country's Economy and 52% Worry Daily About Their Personal Finances Consumers Cut Back on Discretionary Spending; Expect to Increase Spending on Two Fronts: Essentials and Luxury Online Shopping, Sustainability, and Deal-Seeking Reshape Consumer Preferences and Expectations BOSTON, June 10, 2025 /PRNewswire/ -- European consumers are navigating 2025 with growing unease, reevaluating their spending priorities due to economic, political, and environmental concerns. According to a new report by Boston Consulting Group (BCG), more than half (54%) of surveyed European consumers are pessimistic about the economy in their home country—a 7 point increase since July 2024. Meanwhile, 52% worry daily about their personal finances—a 9 point increase from last year. These findings are part of BCG's latest European Consumer Sentiment Report, titled European Consumers Brace for More Uncertainty, based on an April survey of over 16,000 consumers across nine countries. The study reveals a widespread shift toward financial caution and value-driven spending. In addition to economic unease, political anxieties run high, with 57% of Europeans expressing pessimism. But anxiety isn't felt equally: over 73% of consumers in France, 71% in Romania, and 70% in Spain feel pessimistic, compared with just 38% in Scandinavia. The impact of tariffs remains a lesser concern, cited by only 30% of consumers—lower than the 42% of consumers concerned about sustainability and climate change. "Across Europe, consumers are becoming more selective and deal-driven," said Andreas Malby, leader of BCG's Consumer practice in Europe, the Middle East, Africa, and South America, and a coauthor of the report. "With consumers scrutinizing every purchase, brands are now competing on trust, ethics, and value for money." The Hunt for Deals Intensifies Good value for money is the most important purchasing factor in all nine countries surveyed; cited by 59% of consumers. The ability to save and low prices ranked second and third; cited by 48% and 47% of shoppers, respectively. Consumers are cutting back on discretionary items such as apparel (-22% net spending), alcohol (-18%), and snacks (-15%). Spending on household essentials, however, has risen, driven largely by inflation rather than volume. Luxury fashion is bucking the downward trend. High-income consumers and luxury buyers plan to increase spending in this category in the next six months. What Consumers Are Looking For As consumers weather economic uncertainty, they're adjusting their spending priorities and expectations: Physical Stores Aren't Disappearing Just Yet. Compared with 2024, consumers report a modest drop in online shopping as they curb spending on discretionary items. Nearly three-quarters (72%) of consumers deem physical stores essential, indicating a preference toward integrated shopping experiences across channels. Two-day Delivery Is Becoming the Expectation. For categories such as groceries and alcohol, 83% and 71% of consumers expect two-day delivery respectively. Scandinavian consumers, however, are more likely to have lower expectations for delivery speed compared with other European markets. Amid Sustainability Concerns, Consumers Buy Second Hand. Nearly half (45%) consider sustainability when shopping (up 5 percentage points), but only 17% are willing to pay a premium. More consumers are turning to secondhand shopping in response to sustainability concerns. Approximately 20% of European consumers regularly buy apparel, toys, luxury fashion, and furniture second hand. Rates are notably higher in Scandinavia (25% to 35%) than in Spain and Italy (10% to 15%). Before Buying, Consumers Weigh Ethical Implications. More than one-third of consumers say they boycott brands for ethical or political reasons, up 6 percentage points from last year. This shift signals that brands must appeal not only to consumers' wallets, but to their values. "This is a defining moment for consumer companies," Malby said. "Brands should make bold portfolio and pricing decisions while planting seeds for the future. Although the current climate is challenging, growth will return—companies should manage for both today and a brighter tomorrow." Download the publication here: Country-level insights are available for Denmark, France, Germany, Italy, Norway, Romania, Spain, Sweden, and the UK. Media Contact:Eric Gregoire+1 617 850 About Boston Consulting GroupBoston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place. View original content to download multimedia: SOURCE Boston Consulting Group (BCG)
